CoChat

Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Microbial metabolites are known to modulate immune responses of the host. The main metabolites derived from microbial fermentation of dietary fibers in the intestine, short-chain fatty acids (SCFA), affect local and systemic immune functions. Here we show that SCFA are regulators of osteoclast metabolism and bone mass in vivo. Treatment of mice with SCFA as well as feeding with a high-fiber diet significantly increases bone mass and prevents postmenopausal and inflammation-induced bone loss. The protective effects of SCFA on bone mass are associated with inhibition of osteoclast differentiation and bone resorption in vitro and in vivo, while bone formation is not affected. Mechanistically, propionate (C3) and butyrate (C4) induce metabolic reprogramming of osteoclasts resulting in enhanced glycolysis at the expense of oxidative phosphorylation, thereby downregulating essential osteoclast genes such as TRAF6 and NFATc1. In summary, these data identify SCFA as potent regulators of osteoclast metabolism and bone homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02490-4

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 SCFA improve systemic bone mass under steady-state conditions. WT mice not treated (NT) or treated with C2 (acetate), C3 (propionate), or C4 (butyrate) in the drinking water for 8 weeks were analyzed by µCT for a bone volume per total volume (BV/TV) and b trabecular separation (Tb.Sp.). c Representative µCT images of the trabecular part of tibial bone of mice not treated (NT) or treated with SCFA (C2/C3/C4). d Serum CTX-I levels as marker for bone resorption measured by ELISA. e Immunohistological analysis of TRAP-stained osteoclasts in the tibia of SCFA-exposed WT mice showing the number of osteoclasts per analyzed bone parameter (N.Oc./B.pm). f Immunohistological analysis of osteoblasts in the tibia of SCFA-exposed WT mice showing N.Ob./B.pm. g Serum osteocalcin (OCN) bone formation marker measured by ELISA. h-i. RAG1−/ − mice NT or treated with C2/C3/C4 in the drinking water for 8 weeks were analyzed by µCT for h BV/TV and i Tb.Sp. j. Immunohistological analysis of TRAP-stained osteoclasts in the tibia of SCFA-exposed RAG1−/ − mice showing N.Oc./B.pm. k Serum Crosslaps bone resorption marker measured by ELISA before and after 2 weeks of sodium propionate treatment in healthy control human subjects. l Gas-chromatographic mass-spectrometric analysis of SCFA concentrations in cecal samples expressed as mM per gram feces. m, n WT mice fed with special high-fiber diet (HFD) and normal control diet (ND) analyzed by µCT for m BV/TV and n Tb.Sp. o Immunohistological analysis of TRAP-stained osteoclasts in the tibia of WT mice fed with special HFD and ND showing N.Oc./B.pm. p–r WT mice receiving adoptive transfer of isolated Prevotella strains analyzed by p gas-chromatographic mass-spectrometric analysis for SCFA concentration in cecal samples expressed as mM per gram feces and q by µCT for BV/TV. r Representative µCT images of the trabecular part of tibial bone of NT mice or receiving adaptive transfer of isolated Prevotella (P1/P2/P3). Pictures are representative of at least two independent experiments. Data are expressed as the mean ± s.d. Statistical difference was determined by one-way ANOVA or Student's t-test. *p < 0.5; **p < 0.01; ***p < 0.001
Fig. 1 SCFA improve systemic bone mass under steady-state conditions. WT mice not treated (NT) or treated with C2 (acetate), C3 (propionate), or C4 (butyrate) in the drinking water for 8 weeks were analyzed by µCT for a bone volume per total volume (BV/TV) and b trabecular separation (Tb.Sp.). c Representative µCT images of the trabecular part of tibial bone of mice not treated (NT) or treated with SCFA (C2/C3/C4). d Serum CTX-I levels as marker for bone resorption measured by ELISA. e Immunohistological analysis of TRAP-stained osteoclasts in the tibia of SCFA-exposed WT mice showing the number of osteoclasts per analyzed bone parameter (N.Oc./B.pm). f Immunohistological analysis of osteoblasts in the tibia of SCFA-exposed WT mice showing N.Ob./B.pm. g Serum osteocalcin (OCN) bone formation marker measured by ELISA. h-i. RAG1−/ − mice NT or treated with C2/C3/C4 in the drinking water for 8 weeks were analyzed by µCT for h BV/TV and i Tb.Sp. j. Immunohistological analysis of TRAP-stained osteoclasts in the tibia of SCFA-exposed RAG1−/ − mice showing N.Oc./B.pm. k Serum Crosslaps bone resorption marker measured by ELISA before and after 2 weeks of sodium propionate treatment in healthy control human subjects. l Gas-chromatographic mass-spectrometric analysis of SCFA concentrations in cecal samples expressed as mM per gram feces. m, n WT mice fed with special high-fiber diet (HFD) and normal control diet (ND) analyzed by µCT for m BV/TV and n Tb.Sp. o Immunohistological analysis of TRAP-stained osteoclasts in the tibia of WT mice fed with special HFD and ND showing N.Oc./B.pm. p–r WT mice receiving adoptive transfer of isolated Prevotella strains analyzed by p gas-chromatographic mass-spectrometric analysis for SCFA concentration in cecal samples expressed as mM per gram feces and q by µCT for BV/TV. r Representative µCT images of the trabecular part of tibial bone of NT mice or receiving adaptive transfer of isolated Prevotella (P1/P2/P3). Pictures are representative of at least two independent experiments. Data are expressed as the mean ± s.d. Statistical difference was determined by one-way ANOVA or Student's t-test. *p < 0.5; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 2 SCFA suppress osteoclastogenesis by changing cellular metabolism. a Quantification and b representative microphotographs of multinucleated TRAP-positive osteoclasts from in vitro bone marrow cell cultures stimulated with M-CSF and RANKL and treated with 0.5 mM C2, C3, C4, or left untreated (not treated, NT). Scale bar, 1000 µm. c–d Real-time PCR analysis of osteoclast marker genes c TRAF6 and d NFATc1 during osteoclast differentiation after 24 and 48 h of SCFA exposure. e Western blot analysis of TRAF6 and NFATc1 expression after C3 and C4 stimulation for 48 h. f, g Analysis of the extracellular acidification rate (ECAR) by glycolysis measured with a Seahorse real-time metabolic analyzer: f glycolytic capacity and g glycolytic reserve. h Ratio of ECAR to oxygen consumption rate (OCR), the latter resembling mitochondrial activity. i Time course of ECAR values in osteoclasts expose to SCFA. j Representative western blots of total AMPK and phosphorylated AMPK (pAMPK) in osteoclasts not treated (NT) or treated with SCFA (C2/C3/C4) (left panel) and quantification of the pAMPK/AMPK ratio (right panel). k Quantification of multinucleated TRAP-positive osteoclasts from in vitro bone marrow cell cultures stimulated with M-CSF and RANKL and treated with 0.5 mM C3 or 0.25 mM C4 or left untreated (not treated, NT) and incubated with 0.1 mM 2-deoxy-D-glucose (2DG), 2.5 nM oligomycin, 5 nM trichostatin A (TSA), or 10 µM anacardic acid. Pictures are representative of at least three independent experiments. Data are expressed as the mean ± s.d. Statistical difference was determined by one-way or two-way ANOVA. *p < 0.5; **p < 0.01; ***p < 0.001
Fig. 2 SCFA suppress osteoclastogenesis by changing cellular metabolism. a Quantification and b representative microphotographs of multinucleated TRAP-positive osteoclasts from in vitro bone marrow cell cultures stimulated with M-CSF and RANKL and treated with 0.5 mM C2, C3, C4, or left untreated (not treated, NT). Scale bar, 1000 µm. c–d Real-time PCR analysis of osteoclast marker genes c TRAF6 and d NFATc1 during osteoclast differentiation after 24 and 48 h of SCFA exposure. e Western blot analysis of TRAF6 and NFATc1 expression after C3 and C4 stimulation for 48 h. f, g Analysis of the extracellular acidification rate (ECAR) by glycolysis measured with a Seahorse real-time metabolic analyzer: f glycolytic capacity and g glycolytic reserve. h Ratio of ECAR to oxygen consumption rate (OCR), the latter resembling mitochondrial activity. i Time course of ECAR values in osteoclasts expose to SCFA. j Representative western blots of total AMPK and phosphorylated AMPK (pAMPK) in osteoclasts not treated (NT) or treated with SCFA (C2/C3/C4) (left panel) and quantification of the pAMPK/AMPK ratio (right panel). k Quantification of multinucleated TRAP-positive osteoclasts from in vitro bone marrow cell cultures stimulated with M-CSF and RANKL and treated with 0.5 mM C3 or 0.25 mM C4 or left untreated (not treated, NT) and incubated with 0.1 mM 2-deoxy-D-glucose (2DG), 2.5 nM oligomycin, 5 nM trichostatin A (TSA), or 10 µM anacardic acid. Pictures are representative of at least three independent experiments. Data are expressed as the mean ± s.d. Statistical difference was determined by one-way or two-way ANOVA. *p < 0.5; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 3 SCFA protect from postmenopausal bone loss. a Representative µCT images of the trabecular part of tibial bone of WT sham operated (Sham) or ovariectomized (OVX) mice fed with C2, C3, or C4 in the drinking water for 8 weeks or left untreated (not treated, NT). b Bone volume per total volume (BV/TV) and c trabecular separation (Tb.Sp.) analyzed by µCT. d Immunohistological analysis of TRAP-stained osteoclasts in the tibia of mice showing the number of osteoclasts per analyzed bone parameter (N.Oc./B.pm). e Serum CTX-I bone resorption and f osteocalcin (OCN) bone formation marker levels measured by ELISA. Data are expressed as the mean ± s.d. Pictures are representative of at two independent experiments. Statistical difference was determined by one-way ANOVA. *p < 0.5; **p < 0.01; ***p < 0.001
Fig. 3 SCFA protect from postmenopausal bone loss. a Representative µCT images of the trabecular part of tibial bone of WT sham operated (Sham) or ovariectomized (OVX) mice fed with C2, C3, or C4 in the drinking water for 8 weeks or left untreated (not treated, NT). b Bone volume per total volume (BV/TV) and c trabecular separation (Tb.Sp.) analyzed by µCT. d Immunohistological analysis of TRAP-stained osteoclasts in the tibia of mice showing the number of osteoclasts per analyzed bone parameter (N.Oc./B.pm). e Serum CTX-I bone resorption and f osteocalcin (OCN) bone formation marker levels measured by ELISA. Data are expressed as the mean ± s.d. Pictures are representative of at two independent experiments. Statistical difference was determined by one-way ANOVA. *p < 0.5; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 4 SCFA mitigate arthritis and protect from inflammatory bone loss. a–j Collagen-induced arthritis (CIA) model; k–p K/BxN serum-induced arthritis (SIA) model. a Joint swelling and b grip strength scores in mice induced for CIA and not treated (NT) or treated with C2 (acetate), C3 (propionate), or C4 (butyrate) in the drinking water. c µCT analysis of tibial bone mass showing bone volume per total volume (BV/TV). d Immunohistological analysis of TRAP-stained osteoclasts in the tibia of mice showing total osteoclast cell numbers per paw. e Serum CTX-I bone resorption marker level measured by ELISA. f Immunohistological analysis showing the number of osteoblasts per analyzed bone parameter in the tibia (N.Ob./B.pm). g Osteocalcin (OCN) bone formation marker level measured by ELISA. h Joint swelling and i grip strength scores in mice induced for CIA and fed with special high-fiber diet (HFD) or normal control diet (ND). j µCT analysis of tibial bone mass showing BV/TV. k Joint swelling and l grip strength scores in mice induced for SIA and not treated (NT) or treated with C2/C3/C4 in the drinking water. m µCT analysis of tibial bone mass showing BV/TV. n Joint swelling and o grip strength scores in SIA mice fed with special HFD or ND. p µCT analysis of tibial bone mass showing BV/TV. Data are expressed as the mean ± s.d. expect for a, b, h, I, k, l, n, and o where mean ± s.e.m. is shown. Pictures are representative of at least two independent experiments. Statistical difference was determined by one-way ANOVA, two-way ANOVA, or Student's t-test. *p < 0.5; **p < 0.01; ***p < 0.001
Fig. 4 SCFA mitigate arthritis and protect from inflammatory bone loss. a–j Collagen-induced arthritis (CIA) model; k–p K/BxN serum-induced arthritis (SIA) model. a Joint swelling and b grip strength scores in mice induced for CIA and not treated (NT) or treated with C2 (acetate), C3 (propionate), or C4 (butyrate) in the drinking water. c µCT analysis of tibial bone mass showing bone volume per total volume (BV/TV). d Immunohistological analysis of TRAP-stained osteoclasts in the tibia of mice showing total osteoclast cell numbers per paw. e Serum CTX-I bone resorption marker level measured by ELISA. f Immunohistological analysis showing the number of osteoblasts per analyzed bone parameter in the tibia (N.Ob./B.pm). g Osteocalcin (OCN) bone formation marker level measured by ELISA. h Joint swelling and i grip strength scores in mice induced for CIA and fed with special high-fiber diet (HFD) or normal control diet (ND). j µCT analysis of tibial bone mass showing BV/TV. k Joint swelling and l grip strength scores in mice induced for SIA and not treated (NT) or treated with C2/C3/C4 in the drinking water. m µCT analysis of tibial bone mass showing BV/TV. n Joint swelling and o grip strength scores in SIA mice fed with special HFD or ND. p µCT analysis of tibial bone mass showing BV/TV. Data are expressed as the mean ± s.d. expect for a, b, h, I, k, l, n, and o where mean ± s.e.m. is shown. Pictures are representative of at least two independent experiments. Statistical difference was determined by one-way ANOVA, two-way ANOVA, or Student's t-test. *p < 0.5; **p < 0.01; ***p < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 905

Metadata

Authors
Lucas, S., Omata, Y., Hofmann, J., Böttcher, M., Iljazovic, A., Sarter, K., Albrecht, O., Schulz, O., Krishnacoumar, B., Krönke, G., Herrmann, M., Mougiakakos, D., Strowig, T., Schett, G., & Zaiss, M. M.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Universitätsklinikum Erlangen (DE)
  • Helmholtz Centre for Infection Research (DE)
Corresponding author
Zaiss, Mario M.
Venue
Nature Communications
Published
2018-01-04
Volume
9
Issue
1
Pages
55-55
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2778082937
Cited by
815
References
48
Citations by year
2026: 161 · 2025: 123 · 2024: 129 · 2023: 97 · 2022: 95 · 2021: 88 · 2020: 64 · 2019: 36 · 2018: 19
FWCI
13.29
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HZI (Helmholtz Centre for Infection Research) (submittedVersion, cc-by-nc-sa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Johannes und Frieda Marohn-Stiftung
  • Deutsche Forschungsgemeinschaft (CRC‐1181, SPP193 7, SPP1468, GK1660)
  • Else Kröner-Fresenius-Stiftung
  • Novartis Pharma
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
short-chain fatty acids, bone mass, osteoclasts, bone resorption, bone loss, postmenopausal osteoporosis, dietary fiber, microbial metabolites, metabolic reprogramming, glycolysis, oxidative phosphorylation, TRAF6, NFATc1, bone homeostasis, butyrate, propionate
MeSH terms
Animals, Bone and Bones, Bone Resorption, Butyrates, Dietary Fiber, Fatty Acids, Volatile, Female, Glycolysis, Humans, Mice, Inbred C57BL, Osteoclasts, Propionates, Bone Density, Gene Expression, Protective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. https://app.cochat.ai/papers/10.1038/s41467-017-02490-4
The paper
Lucas, S., Omata, Y., Hofmann, J., Böttcher, M., Iljazovic, A., Sarter, K., Albrecht, O., Schulz, O., Krishnacoumar, B., Krönke, G., Herrmann, M., Mougiakakos, D., Strowig, T., Schett, G., & Zaiss, M. M. (2018). Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nature Communications. https://doi.org/10.1038/s41467-017-02490-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.